Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction.Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now